Insider Transactions in Q2 2021 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2021
|
Daniel E. Owens |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$68,000
$17.0 P/Share
|
|
Apr 27
2021
|
F Barry Bays |
BUY
Conversion of derivative security
|
Direct |
413,326
+19.3%
|
-
|
|
Apr 27
2021
|
James T Treace |
BUY
Conversion of derivative security
|
Indirect |
569,067
+27.79%
|
-
|
|
Apr 27
2021
|
James T Treace |
BUY
Conversion of derivative security
|
Direct |
399,633
+15.34%
|
-
|
|
Apr 27
2021
|
Jaime A. Frias Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
329,230
-88.5%
|
$5,596,910
$17.0 P/Share
|
|
Apr 27
2021
|
Jaime A. Frias Chief Legal Officer |
BUY
Conversion of derivative security
|
Direct |
42,785
+10.31%
|
-
|
|
Apr 27
2021
|
Jaime A. Frias Chief Legal Officer |
BUY
Conversion of derivative security
|
Indirect |
85,570
+27.5%
|
-
|
|
Apr 27
2021
|
John K Bakewell |
BUY
Conversion of derivative security
|
Indirect |
342,300
+50.0%
|
-
|
|
Apr 27
2021
|
John R Treace Director |
SELL
Open market or private sale
|
Indirect |
401,250
-14.82%
|
$6,821,250
$17.0 P/Share
|
|
Apr 27
2021
|
John R Treace Director |
BUY
Conversion of derivative security
|
Indirect |
427,875
+13.65%
|
-
|
|
Apr 27
2021
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,600
+50.0%
|
$61,200
$17.0 P/Share
|
|
Apr 27
2021
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$170,000
$17.0 P/Share
|
|
Apr 27
2021
|
Richard W Mott |
BUY
Conversion of derivative security
|
Direct |
699,141
+29.17%
|
-
|
|
Apr 27
2021
|
Thomas E Timbie Director |
BUY
Conversion of derivative security
|
Indirect |
299,509
+9.6%
|
-
|
|
Apr 27
2021
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,253,805
-47.03%
|
$89,314,685
$17.0 P/Share
|
|
Apr 27
2021
|
John T. Treace Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
299,510
+2.61%
|
-
|
|
Apr 27
2021
|
Joe W. Ferguson SVP, Research & Development |
BUY
Conversion of derivative security
|
Indirect |
85,575
+50.0%
|
-
|